North America Digital Pathology Market to Reach $3,492.3 Million by 2035

North America digital pathology market was valued at $531.5 million in 2025 and is projected to reach $3,492.3 million by 2035, growing at a CAGR of 20.8% during the forecast period (2026–2035). The North American digital pathology market is increasingly shifting from traditional analog methods toward digitally enabled workflows. Pathology laboratories are adopting whole slide imaging and digital platforms to improve workflow consistency and enable remote review. This transition is supported by growing integration of digital systems with laboratory information systems and hospital networks. Regulatory acceptance and clinical validation have contributed to wider routine use in diagnostic settings. Adoption remains uneven, with larger institutions moving faster than smaller laboratories. Overall, the market reflects a measured transition rather than a rapid transformation.

Browse the full report description of “North America Digital Pathology Market Size, Share & Trends Analysis Report by Product (Scanner Device, Software and Storage System), by Application (Teleconsultation, Disease Diagnosis and Drug Discovery and Other) and by End-User (Biotechnology & Pharmaceutical Companies, Hospitals and Others), Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/north-american-digital-pathology-market

Major digital pathology players based in Europe are increasingly expanding their footprint in the United States. These companies are entering the US market through new laboratory setups, new solution availability, partnerships with healthcare providers, and selective acquisitions. For instance, Expansion strategies are often informed by prior deployment experience within regulated European healthcare systems. In July 2024, AGFA HealthCare launched Enterprise Imaging for Pathology, powered by Corista DP3, in North America, making the digital pathology solution available to healthcare providers transitioning from analog workflows. The platform supports whole slide imaging, integrated case management, and secure inter-organizational collaboration within AGFA HealthCare’s enterprise imaging environment, with capabilities to support AI-enabled pathology applications. Expansion strategies are often informed by prior deployment experience within regulated European healthcare systems.

Strategic Initiatives and Competitive Developments in the North America Digital Pathology Market

The major companies operating in the North America digital pathology market include Akoya Biosciences, Inc., F. Hoffmann-La Roche Ltd. (Ventana), Leica Biosystems Nussloch GmbH, Philips N.V., and Proscia, Inc., among others. market players in the North America digital pathology market are actively expanding digital workflows, strengthening AI integration, and forming strategic partnerships to address rising diagnostic volumes and workforce constraints. These initiatives focus on enhancing operational efficiency, improving diagnostic accuracy, and scaling enterprise-wide digital pathology adoption across anatomic pathology services.

• In September 2025, Labcorp announced a collaboration with Roche to advance its digital pathology capabilities, implementing Roche’s FDA-cleared VENTANA DP 600 and DP 200 slide scanners across its anatomic pathology services. The initiative enables pathologists to diagnose using high-resolution digital images, improves workflow efficiency, and establishes a foundation for future AI integration amid growing diagnostic demand and a projected U.S. pathologist shortage.

• In May 2024, Quest Diagnostics and PathAI announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases. Under the terms of a definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides anatomic and digital pathology laboratory services.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product
  • By Application
  • By End-User
• Competitive Landscape - Akoya Biosciences, Inc., F. Hoffmann-La Roche Ltd. (Ventana), Leica Biosystems Nussloch GmbH, Philips N.V., and Proscia, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Digital Pathology Market Report Segment

By Product Type

• Scanner Device
• Software
• Storage System

By Application

• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Other

By End-User

• Biotechnology & Pharmaceutical Companies
• Hospitals
• Others

North America Digital Pathology Market Report Segment by Region

• US
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-digital-pathology-market